Murata Yukiko, Tatsugami Katsunori, Yoshikawa Masahiro, Hamaguchi Masumitsu, Yamada Shigetomo, Hayakawa Yusuke, Ueda Kouhei, Momosaki Seiya, Sakamoto Naotaka
Department of Urology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, , Japan.
Int J Urol. 2018 Mar;25(3):284-289. doi: 10.1111/iju.13514. Epub 2018 Jan 8.
To identify risk factors of biochemical recurrence after radical prostatectomy in high-risk patients.
A total of 191 high-risk prostate cancer patients according to the D'Amico classification treated with radical prostatectomy at a single institution between April 2000 and December 2013 were enrolled. The pathological evaluation including intraductal carcinoma of prostate was reassessed, and the clinical and pathological risk factors of biochemical recurrence were analyzed.
The median follow up after radical prostatectomy was 49 months. The 5-year biochemical recurrence-free survival rate after radical prostatectomy in high-risk prostate cancer patients was 41.6%. Initial prostate-specific antigen, pathological Gleason score, seminal vesicle invasion, extraprostatic extension and intraductal carcinoma of the prostate were significantly associated with biochemical recurrence-free survival. The 5-year biochemical recurrence-free survival rates in patients with zero, one, two and three of these risk factors were 92.9%, 70.7%, 38.3% and 28.8%, respectively. In patients with four or more factors, the biochemical recurrence-free survival rate was 6.1% after 18 months.
In D'Amico high-risk patients treated with radical prostatectomy, risk factors for biochemical recurrence can be identified. Patients with fewer risk factors have longer biochemical recurrence-free survival, even among these high-risk cases.
确定高危患者根治性前列腺切除术后生化复发的危险因素。
纳入2000年4月至2013年12月期间在单一机构接受根治性前列腺切除术的191例根据达米科分类法确定的高危前列腺癌患者。重新评估包括前列腺导管内癌在内的病理评估,并分析生化复发的临床和病理危险因素。
根治性前列腺切除术后的中位随访时间为49个月。高危前列腺癌患者根治性前列腺切除术后5年无生化复发生存率为41.6%。初始前列腺特异性抗原、病理Gleason评分、精囊侵犯、前列腺外扩展和前列腺导管内癌与无生化复发生存显著相关。这些危险因素个数为零、一、二和三个的患者5年无生化复发生存率分别为9².9%、70.7%、38.3%和28.8%。有四个或更多危险因素的患者,18个月后的无生化复发生存率为6.1%。
在接受根治性前列腺切除术的达米科高危患者中,可以确定生化复发的危险因素。即使在这些高危病例中,危险因素较少的患者无生化复发生存时间也更长。